Sarepta Therapeutics (SRPT) Announces Appointment Of John Hodgman As Interim Chairman
8/1/2014 9:10:32 AM
Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a developer of innovative RNA-based therapeutics, announced today that John Hodgman, a member of Sarepta’s board of directors, has been named interim chairman, effective July 30, 2014. William Goolsbee, chairman of the company’s board of directors, has resigned as chairman and will continue to serve on the Sarepta board as an independent director.
Help employers find you! Check out all the jobs and post your resume.
comments powered by